期刊文献+

色谱二维光谱相关法识别莫西沙星中的杂质 被引量:2

Identification of impurities in Moxifloxacin by chromatographic two-dimensional spectroscopy correlation
下载PDF
导出
摘要 目的建立识别HPLC色谱图中莫西沙星杂质色谱峰的色谱二维光谱相关方法。方法采用高效液相色谱-二极管阵列检测器(HPLC-DAD),建立杂质标准色谱光谱数据;通过样品的色谱光谱数据与标准色谱光谱数据的二维相似计算,对杂质进行识别。结果色谱二维光谱相关法在不同色谱系统下均能准确定性,对样品中杂质判断结果与质谱法一致,识别的最低检出限为30 ng。结论色谱二维光谱相关法可有效地对HPLC分析中的色谱峰进行识别,具有准确度高、耐用性好、多组分同时快速定性的特点,适用于归属因色谱柱、流动相等色谱条件的改变,无法利用相对保留时间定性的色谱峰。 OBJECTIVE To establis a qualitative analysis method to identify related substances of Moxifloxacin by correlation of spectra in chromatography. METHODS Standard chromatographic and spectral data obtained by high - performance liquid chromatograpy with diode army detection(HPLC - DAD) were developed and used in identification of peaks in samples by calculating correlation coefficients. RESULTS Peaks in chromatography can be identified accurately and rapidly through chromatographic system such as column and mobile phase change. The liufit amount for identification was 30 ng. CONCLUSION The method is accurate and reproducible as a new and effective way to identify multi- components in drugs when relative retention times are incapable due to changes of chromaatographic system.
出处 《华西药学杂志》 CAS CSCD 北大核心 2006年第3期270-272,共3页 West China Journal of Pharmaceutical Sciences
关键词 色谱二维光谱相关法 高效液相色谱一二极管阵列检测器 莫西沙星 杂质 鉴别 Chromatographic two- dimensional spectroscopy con'elation HPLC- DAD Moxifloxacin Impurities Identification
  • 相关文献

参考文献3

  • 1Y Ravindra K, WNKV Prasad R, R Rajesh K, et al. Structural identification and characterization of impurities in moxifloxacin [ J ]. J Pharm Biomed Anal,2004,34(5): 1125- 1129.
  • 2Sunderland J, Tobin CM, Hedges A J, et al. Antimicrobial activity of fluoroquinolone photodegradation products determinated by parallel -line bioassay and high - performance liquid chromatography [ J ]. J Antimicrob chemother, 2001,47(3): 271 - 275.
  • 3朱斌,胡昌勤,蒋受军,尹利辉.高效液相色谱法测定莫西沙星制剂含量[J].中国抗生素杂志,2002,27(8):462-464. 被引量:28

二级参考文献6

  • 1[1]Woodcock J M, Andrews J M, Boswell F J. et al. In vitro activity of BAY 12-8039, a new fluoroquinolone [J]. Antimicrob AgentsChemother , 1997;41:1101
  • 2[2]Hoogkamp-Korstanje J A, Roelofs-Winemse J. Comparative invitro activity of moxitloxacin against Gram-positive clinical isolates[J]. J Antimicrob Chemother, 2000; 45 (1): 31
  • 3[3]Sunderland J, Tobin C M, Hedges A J, et al. Antimicrobial activity of fluoroquinolone photodegradation products determinated byparallel-line bioassay and high performance liquid chromatography[J]. JAntimicrob Chemother, 2001; 47 (3): 271
  • 4[4]Stass H, Kubitza D. Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administation in man [J]. JAntimicrob Chemother, 1999; 43 (Supple B): 83
  • 5[5]Stass H, Dalhoff A. Determination of BAY12-8039, a new 8methoxyquinolone, in human body fluids by high-performance liqnid chromatography with fluorescence detection using on-columnfocusing [J]. J Chromatogr Biomed Appl, 1997; 702 ( 1 ~ 2):163
  • 6[6]Moller J G, Stass H, Heinig R, et al. Capillary electrophoresiswith laser-induced fluorescence: a routine method to determinemoxifloxacin in human body fluids in very small sample volumes[J]. J Chromatog, 1998; 716:325

共引文献27

同被引文献2123

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部